| Julie Lynn West, | |
|
26 Queen St, Worcester, MA 01610-2473 | |
| (508) 334-2670 | |
| Not Available |
| Full Name | Julie Lynn West |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 26 Queen St, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013527423 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 9005 (Connecticut) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | RN2364699 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lumin Health Pg | 3678950649 | 5 |
| Umass Memorial Medical Group Inc | 4284539891 | 1889 |
News Archive
UC Davis investigators have found new evidence that a promising type of stem cell now being considered for a variety of disease therapies is very similar to the type of cells that give rise to cancer. The findings suggest that although the cells - known as induced pluripotent stem cells (iPSCs) - show substantial promise as a source of replacement cells and tissues to treat injuries, disease and chronic conditions, scientists and physicians must move cautiously with any clinical use because iPSCs could also cause malignant cancer.
Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.
Hitachi High-Technologies Corporation has announced the development and release of the HT7700, a new type of transmission electron microscope (TEM) that integrates previously complex system operation onto a single monitor screen, and allows for sample observation even under normal room light conditions. Sales of the HT7700 will begin outside of Japan in August 2010.
Encorium Group, Inc., a full service multinational clinical research organization conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced its financial results for the fourth quarter and year ended December 31, 2009.
› Verified 9 days ago
| Entity Name | Umass Memorial Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760445373 PECOS PAC ID: 4284539891 Enrollment ID: O20040113000267 |
News Archive
UC Davis investigators have found new evidence that a promising type of stem cell now being considered for a variety of disease therapies is very similar to the type of cells that give rise to cancer. The findings suggest that although the cells - known as induced pluripotent stem cells (iPSCs) - show substantial promise as a source of replacement cells and tissues to treat injuries, disease and chronic conditions, scientists and physicians must move cautiously with any clinical use because iPSCs could also cause malignant cancer.
Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.
Hitachi High-Technologies Corporation has announced the development and release of the HT7700, a new type of transmission electron microscope (TEM) that integrates previously complex system operation onto a single monitor screen, and allows for sample observation even under normal room light conditions. Sales of the HT7700 will begin outside of Japan in August 2010.
Encorium Group, Inc., a full service multinational clinical research organization conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced its financial results for the fourth quarter and year ended December 31, 2009.
› Verified 9 days ago
| Entity Name | Lumin Health Pg |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538819909 PECOS PAC ID: 3678950649 Enrollment ID: O20220512000770 |
News Archive
UC Davis investigators have found new evidence that a promising type of stem cell now being considered for a variety of disease therapies is very similar to the type of cells that give rise to cancer. The findings suggest that although the cells - known as induced pluripotent stem cells (iPSCs) - show substantial promise as a source of replacement cells and tissues to treat injuries, disease and chronic conditions, scientists and physicians must move cautiously with any clinical use because iPSCs could also cause malignant cancer.
Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.
Hitachi High-Technologies Corporation has announced the development and release of the HT7700, a new type of transmission electron microscope (TEM) that integrates previously complex system operation onto a single monitor screen, and allows for sample observation even under normal room light conditions. Sales of the HT7700 will begin outside of Japan in August 2010.
Encorium Group, Inc., a full service multinational clinical research organization conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced its financial results for the fourth quarter and year ended December 31, 2009.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julie Lynn West, Po Box 415348, Boston, MA 02241-5348 Ph: () - | Julie Lynn West, 26 Queen St, Worcester, MA 01610-2473 Ph: (508) 334-2670 |
News Archive
UC Davis investigators have found new evidence that a promising type of stem cell now being considered for a variety of disease therapies is very similar to the type of cells that give rise to cancer. The findings suggest that although the cells - known as induced pluripotent stem cells (iPSCs) - show substantial promise as a source of replacement cells and tissues to treat injuries, disease and chronic conditions, scientists and physicians must move cautiously with any clinical use because iPSCs could also cause malignant cancer.
Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.
Hitachi High-Technologies Corporation has announced the development and release of the HT7700, a new type of transmission electron microscope (TEM) that integrates previously complex system operation onto a single monitor screen, and allows for sample observation even under normal room light conditions. Sales of the HT7700 will begin outside of Japan in August 2010.
Encorium Group, Inc., a full service multinational clinical research organization conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced its financial results for the fourth quarter and year ended December 31, 2009.
› Verified 9 days ago